JPRN-jRCT2080222562已完成3 期
Open study of quadrivalent VN-100 in Japanese healthy volunteers
DAIICHISANKYO Co.,Ltd.0 个研究点目标入组 150 人开始时间: 2014年7月23日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
As a result of 2nd intradermal vaccinated of quadrivalent VN-100 in healthy Japanese 13 years and older, no serious AEs or AEs leading to this study discontinuation occurred. Therefore we thought there was no serious issues with safety. In addition, HI antibody titer, SRH antibody titer, and neutralizing antibody titer increased after vaccinated of quadrivalent VN-100, confirming good immunogenicity.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 13age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Japanese healthy volunteers
排除标准
- •1) Subjects with history of seasonal influenza in the past 6 months
- •2) Subjects with history of seasonal influenza vaccination in the past 6 months
研究者
相似试验
已完成
3 期
VN-100 Ph3 non-inferiority studyProphylaxis of influenza infectionJPRN-jRCT2080222443DAIICHISANKYO Co.,Ltd.901
已完成
3 期
Open study of quadrivalent VN-100 in healthy childreProphylaxis of influenza infectionJPRN-jRCT2080222939DAIICHISANKYO Co.,Ltd.73
已完成
1 期
Safety and Immunogenicity of V114 in Healthy Japanese InfantsPrevention of Pneumococcal InfectionsJPRN-jRCT2080224598MSD K.K.133
已完成
1 期
VN-100 Ph1/2JPRN-jRCT2080222050DAIICHISANKYO Co.,Ltd.600
未知
2 期
Clinical trial of VN-0104 in Japanese healthy adult volunteersProphylaxis of influenza infectionJPRN-jRCT2080222536DAIICHISANKYO Co.,Ltd.50